Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (181)

Latest news

  • Medication Reformulations: When Companies Change Drug Formulas
  • Stroke Types: Ischemic vs. Hemorrhagic and Prevention Strategies
  • Generic Drug Recalls and Safety Alerts: What Triggers Action
  • Ketamine and Esketamine: Rapid-Acting Options for Treatment-Resistant Depression
  • Direct Oral Anticoagulants vs Warfarin: Side Effect Comparison

Posts Tags

  • drug interactions
  • online pharmacy
  • medication safety
  • side effects
  • medication reconciliation
  • medication errors
  • patient safety
  • online pharmacy safety
  • generic medication
  • medication side effects
  • bioequivalence
  • generic drugs
  • dietary supplement
  • patient communication
  • reemerging influenza
  • antihistamine side effects
  • diarrhea treatment
  • alternative treatments
  • erectile dysfunction medication
  • allergic rhinitis
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.